Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SOBRsafe is a publicly traded health technology and medical device company developing non-invasive, transdermal alcohol detection and monitoring products. Its core offerings include SOBRcheck, a touch-based alcohol screening system for point-of-access and workplace or institutional use, and SOBRsure, a wearable wristband for continuous alcohol monitoring, alerts, GPS-enabled accountability, and cloud-based reporting. The company positions these products as wellness and behavioral-awareness tools rather than diagnostic medical devices, and integrates proprietary hardware with cloud software to deliver real-time data to individuals, families, and organizations. SOBRsafe focuses on commercializing alcohol-monitoring solutions for markets such as behavioral wellness, personal wellness, family accountability, school transportation, fleet safety, and facility access.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SOBRsafe.